App-Quantinova.ai

Different mortality, recurrence and bleeding between cancer and non cancer patients with pulmonary embolism (PE): 1 year follow-up

Letizia Marconi - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Sleep Disordered Breathing (SDB) and Chronic Thromboembolic Pulmonary Hypertension: the Effects of Pulmonary Endoarterectomy

Francesco Fanfulla - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Totally implantable central venous access ports for M/XDR-TB treatment

Aliaksandr Skrahin - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Proposing a Risk-Factor Based Clinical App to Predict Outcomes Following Initial Hospitalization in Patients with Multiple Sclerosis

Kanika Sharma - Americas Committee For Treatment and Research in Multiple Sclerosis (ACTRIMS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Biochemical differences in patients with COPD due to tobacco and COPD by Biomass hospitalized in the intensive care unit

Marcos Alejandro Escobar Penagos - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Comparison of risk prediction scores for venous thromboembolism in lung cancer patients: a retrospective cohort study

Houda Rouis - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Association between risk stratification for pulmonary embolism and deep vein thrombosis of lower extremities

Xiaohui Wang - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Factors related to hospital stay of patients with pulmonary thromboembolism

Jacinto Hernandez Borge - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Late Breaking Abstract - Frequency Pulmonary embolism (PE) in patients with an acute Exacerbation of chronic obstructive Pulmonary disease (COPD). PEP prospective trial

Francis Couturaud - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Modification of the simplified PESI score to identify low risk patients with acute symptomatic pulmonary embolism

Diana Paulina Chiluiza Reyes - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

A single centre experience of low dose direct oral anticoagulants (DOAC) after unprovoked venous thromboembolism (VTE)

William Thomas - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Pulmonary Embolism Registry of a South American Hospital

Pablo Ram�n Gil Torres - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Anti-Factor Xa levels correlate with recurrent venous thromboembolism and clinically relevant bleeding in patients receiving low-molecular-weight heparin

Luis Jara-Palomares - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Unusual Presentation of a Systemic Disease: A Case Report

Harshil Alwani - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Pradax

Thromboprophylaxis (TP) in Pulmonology department in Galdakao-Usansolo Hospital

Leyre Chasco Eguilaz - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Lung Cancer

Yavuz Havlucu - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Categorising sub-massive pulmonary thromboembolism: no isolated role for shock index or its modified form

Saleel Punnilath Abdulsamad - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

NTP42, an antagonist of the thromboxane receptor, attenuates experimentally-induced pulmonary arterial hypertension

B. Therese Kinsella - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Monocrotaline

Lung vessels thrombosis in patients with lethal severe community-acquired pneumonia: electronic microscopies with 3D modeling

Kseniia Bielosludtseva - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The comparison of diagnostic relevance of protein C, C-reactive protein and endothelin-1 for prediction of lung vessel thrombosis in patients with community-acquired pneumonia

Kseniia Bielosludtseva - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

endothelin-1

Filters

7277 Abstracts